Insulin Glargine Associated With Breast Cancer Risk in T2D
Women who received insulin glargine, compared with neutral protamine Hagedorn insulin, had a higher incidence of breast cancer.
High circulating total prolactin concentrations may be linked with a lower risk for type 2 diabetes in women.
Dapagliflozin was not associated with either a higher or lower rate of MACE compared with placebo in patients with type 2 diabetes who had or were at risk for atherosclerotic ...
The study compared US administrative claims data of HCV patients with ≥12 weeks of dispensed DAA therapy (N = 17,848) to untreated HCV patients with follow-up data (N = 108,350).